Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02049541
Title Study of BKM120; Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kami Maddocks
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Atlanta Georgia 30322 United States Details
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field